On April 11th, Kumulus, an electronic cigarette vendor, announced their intention to purchase over 50 specialized retail stores in France. This move comes as a part of Kumulus' strategic plan following two previous acquisitions at the end of December 2022.
This acquisition represents a crucial step for Kumulus, which has achieved an average annual compound growth rate of nearly 80% over the past five years. By combining the strengths and expertise of both companies, Kumulus aims to accelerate its growth and further solidify its position in the French e-cigarette market.
Kumulus' investment in specialty store networks may increase sales and improve their bargaining power with manufacturers. This acquisition also positions Kumulus as one of the companies with the highest number of physical stores in France.
Read more:
France forbids influential people from advertising e-cigarettes.
The CBD market in France reaches a size of 500 million euros and boasts 2,000 retail stores.
ELFBAR has entered the French market in February with plans to sell its product in 4,000 retail stores.
Reference:
Kumulus Vape will showcase at the Vapexpo 2023 exhibition in Lyon.
Disclaimer
This article is provided solely for professional research, industry discussion, and informational purposes. Any references to brands, companies, products, technologies, or policies are made for factual reporting and analytical purposes only, and do not constitute endorsement, recommendation, promotion, or advertising by 2Firsts.
Nicotine-containing products, including but not limited to cigarettes, e-cigarettes, heated tobacco products, and nicotine pouches, carry significant health risks. Readers are responsible for complying with all applicable laws and regulations in their respective jurisdictions, including age restrictions and access limitations.
The information contained in this article should not be regarded as investment, legal, medical, regulatory, or commercial advice. While 2Firsts strives to ensure the accuracy and reliability of its content, it does not assume liability for any direct or indirect loss arising from errors, omissions, inaccuracies, or reliance on the information contained herein.
This article is not intended for individuals below the legal age for accessing tobacco or nicotine-related information in their jurisdiction.
Copyright Notice
This article is either original content produced by 2Firsts or content reproduced, translated, summarized, or adapted from third-party sources with attribution where applicable. The intellectual property rights of the original content remain with 2Firsts or the respective original rights holders.
No individual or organization may copy, reproduce, distribute, republish, modify, translate, or otherwise use this content without prior authorization. Any unauthorized use may result in legal action.
For copyright-related inquiries, corrections, or removal requests, please contact: info@2firsts.com.
AI-Assisted Translation and Editing Notice
Portions of this article may have been translated, edited, or reviewed with the assistance of artificial intelligence tools to improve efficiency and readability. Due to the limitations of AI-assisted translation and editing, discrepancies, omissions, or inaccuracies may exist when compared with the original source.
Where applicable, readers are advised to refer to the original source for the most complete and accurate information. If you identify any errors or believe that any content infringes upon your rights, please contact us at info@2firsts.com, and we will review and address the matter promptly.
